GlassScriptPhysician profile
Pradeep Kumbham
NPI 1588079560
$1,561.54
in general payments reported to CMS, 2019-2025
8 companies · $211 in 2025
The $211 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $872 · 2020: $24.20 · 2021: $181 · 2022: $120 · 2023: $154 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $364.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $364.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $751.81 | 2019 | |
| Amgen INC. | $210.65 | 2025 | Tavneos |
| Biohaven Pharmaceuticals, INC. | $180.62 | 2021 | |
| Genzyme Corporation | $120.59 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $120.00 | 2022 | |
| Alexion Pharmaceuticals, INC. | $115.64 | 2023 | Ultomiris |
| Janssen Pharmaceuticals, INC | $38.03 | 2023 | Xarelto |
| Eisai INC. | $24.20 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pradeep Kumbham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.